Lumiracoxib, CAS [[220991-20-8]]

Produktübersicht

• Artikelname: Lumiracoxib, CAS [[220991-20-8]]
• Artikelnummer: BYT-ORB1300646
• Hersteller Artikelnummer: orb1300646
• Alternativnummer: BYT-ORB1300646-1, BYT-ORB1300646-10, BYT-ORB1300646-100, BYT-ORB1300646-25, BYT-ORB1300646-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Prexige, bone cancer, Cyclooxygenase, COX, COX 189, COX-1, COX189, COX-189, COX-2, Lumiracoxib, Metabolic Syndrome, osteoarthritis, inflammatory, inhibit, Inhibitor, hyperalgesic

Produktbeschreibung

Lumiracoxib (Prexige) is a highly selective COX-2 inhibitor, demonstrating potent activity with an IC50 of 0.14 µM and over 500-fold selectivity versus COX-1. This compound has been utilized in research models to investigate inflammation, pain pathways, and cardiovascular effects in both cellular and animal studies.

Produkteigenschaften

• Molekulargewicht: 293.72
• Reinheit: 99.77% (May vary between batches)
• CAS Nummer: [220991-20-8]
• Formel: C15H13ClFNO2
• Target-Kategorie: COX

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),Ethanol:< 1 mg/mL (insoluble or slightly soluble),DMSO:55 mg/mL (187.25 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.81 mM)